Apoptotic signaling components

Apoptotic signaling components comprise the intricate network of proteins and molecules responsible for orchestrating programmed cell death, a vital process for maintaining tissue homeostasis and eliminating damaged or potentially malignant cells (1.2.1, 1.2.3). This machinery is broadly divided into the intrinsic (mitochondrial) pathway, which is regulated by the Bcl-2 family of proteins and involves the release of cytochrome c, and the extrinsic (death receptor) pathway, initiated by ligands such as TRAIL or TNF binding to their respective receptors (1.2.2, 1.3.2). Central to both pathways are caspases, a family of cysteine proteases that act as the primary executioners of the apoptotic program (1.2.5, 1.3.3). Dysregulation of these components is a hallmark of various diseases; for instance, cancer cells frequently evade apoptosis by overexpressing anti-apoptotic proteins like Bcl-2 or XIAP, while excessive apoptotic activity is linked to neurodegenerative and cardiovascular disorders (1.2.2, 1.2.4). Therapeutic interventions often focus on modulating these components, such as using BH3 mimetics (e.g., venetoclax) to inhibit anti-apoptotic Bcl-2 proteins or IAP antagonists to sensitize tumor cells to death signals (1.1.1, 1.2.5). These strategies aim to restore the natural cell death balance, though challenges such as off-target toxicity and the development of resistance through alternative pathways remain significant hurdles in clinical application (1.1.1, 1.2.2).

Other names

Apoptosis signaling pathwayProgrammed cell death machineryApoptotic cascade componentsApoptotic signaling molecules

Modulation of the balance between pro-apoptotic and anti-apoptotic signals to regulate programmed cell death, typically by inhibiting anti-apoptotic proteins (e.g., Bcl-2) or activating pro-apoptotic pathways (e.g., death receptors).